• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-04-21

  Schwartz (2022) introduces a refined framework for evaluating anticancer drug responses by distinguishing between relative and fractional viability in in vitro assays. This approach improves the interpretation of cell proliferation and death, enhancing the accuracy of preclinical drug assessments and offering practical implications for optimizing experimental design.

• Selective Nanomolar IRAP Inhibitors: Bestatin Derivative Adv

  2026-04-20

  This study introduces a synthetic strategy to create highly selective, nanomolar inhibitors for insulin-regulated aminopeptidase (IRAP) based on α-hydroxy-β-amino acid derivatives of bestatin. Structural and biochemical analyses reveal determinants of potency and selectivity, offering new chemical tools for probing M1 aminopeptidase biology and potentially informing cancer and immunotherapy research.

• Berbamine Hydrochloride: Redefining NF-κB Inhibition in HCC

  2026-04-20

  This thought-leadership article explores the mechanistic and translational potential of Berbamine hydrochloride as a next-generation NF-κB activity inhibitor in hepatocellular carcinoma (HCC) research. Integrating insights from the METTL16-SENP3-LTF axis and recent advances in ferroptosis resistance, we provide actionable guidance for experimental design, compare competitive products, and articulate a strategic vision for translational researchers. This article extends beyond conventional product pages, offering a critical bridge between molecular mechanisms and future clinical impact.

• Naftifine HCl: Optimizing Antifungal Workflows & Research As

  2026-04-19

  Naftifine HCl, a high-purity allylamine antifungal agent from APExBIO, enables precise inhibition of sterol biosynthesis in dermatophyte research. This guide delivers actionable experimental protocols, troubleshooting strategies, and workflow enhancements, drawing on cross-referenced literature and pioneering cell signaling insights.

• Magnetic Stimulation Modulates GABAA ε Subunit in SCZ Models

  2026-04-18

  This study demonstrates that combined magnetic stimulation system treatment (c-MSST) precisely targeting the left prelimbic cortex downregulates GABAA receptor ε (GABRE) subunit expression, alleviating schizophrenia-like behaviors in mouse models. The findings identify Gabre as a mechanistic node for intervention, offering new insights for both neuromodulation and pharmacological strategies in schizophrenia research.

• PNU 74654: Precision Wnt Signaling Pathway Inhibitor in Rese

  2026-04-17

  PNU 74654 empowers researchers to dissect the Wnt/β-catenin signaling pathway in cancer and stem cell models with unmatched specificity. Its robust solubility profile and high purity make it ideal for reproducible in vitro assays, particularly when exploring cell fate, proliferation, and differentiation.

• Annexin V: Strategic Guidance for Translational Apoptosis Re

  2026-04-16

  This thought-leadership article delivers a rigorous, mechanistic exploration of Annexin V’s role as a phosphatidylserine binding protein in apoptosis assays. Bridging foundational biochemistry, competitive product intelligence, and hands-on workflow guidance, it provides translational researchers with actionable insights for experimental design and data interpretation. Drawing from landmark structural studies and advanced workflow recommendations, we position APExBIO’s Annexin V, human recombinant as a high-performance, flexible reagent suited for next-generation cell death research.

• Jasplakinolide (SKU B7189): Reliable Actin Polymerization fo

  2026-04-15

  This article addresses core challenges in cell viability, cytotoxicity, and proliferation assays by exploring how Jasplakinolide (SKU B7189) serves as a robust actin polymerization inducer. Real-world laboratory scenarios are analyzed, offering workflow-focused guidance and linking directly to validated protocol strategies for researchers seeking reproducible, high-quality results.

• Parathyroid hormone (1-34) (human) in Bone and Kidney Models

  2026-04-14

  Parathyroid hormone (1-34) (human) empowers high-fidelity bone and kidney disease modeling by delivering potent, reproducible receptor signaling and robust calcium regulation. Leveraging recent advances in assembloid technology, this PTH (1-34) peptide fragment enhances experimental workflows for both in vitro and in vivo studies.

• Protease Inhibitor Cocktail EDTA-Free: Precision in Protein

  2026-04-13

  APExBIO’s Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) empowers researchers to preserve protein integrity and phosphorylation states during extraction, especially in workflows sensitive to divalent cations. Its broad inhibition profile, EDTA-free formulation, and compatibility with phosphorylation analysis make it a uniquely versatile tool for modern molecular biology.

• Spatial Transcriptomics Uncovers Cortical Lewy Pathology Mec

  2026-04-12

  This study applies spatial transcriptomics to profile molecular dysfunction in cortical neurons bearing Lewy pathology in Parkinson’s disease and related dementias. The authors identify specific neuron subtypes vulnerable to α-synuclein inclusions and define a conserved transcriptomic signature of dysfunction, providing new insights into disease mechanisms and cellular vulnerability.

• Applied Use of EZ Cap™ Human PTEN mRNA (ψUTP) in Cancer Mode

  2026-04-12

  EZ Cap™ Human PTEN mRNA (ψUTP) empowers researchers to restore PTEN function and overcome PI3K/Akt-driven resistance in advanced cancer workflows. This article guides users through optimized protocols, troubleshooting, and the unique translational impact of pseudouridine and Cap1 engineering for robust, low-immunogenic mRNA delivery.

• Pifithrin-α: Applied Protocols for p53 Inhibition in Neuroto

  2026-04-11

  Unlock the power of Pifithrin-α (PFTα) as a precision p53 inhibitor in experimental neurotoxicology. This article delivers actionable workflows, troubleshooting guidance, and evidence-driven protocol parameters to maximize p53-dependent apoptosis inhibition and protect neuronal systems from environmental insults.

• Canagliflozin: SGLT2 Inhibitor Workflow Innovations in Diabe

  2026-04-11

  Canagliflozin empowers researchers to dissect renal glucose reabsorption and mitochondrial remodeling in diabetic models, surpassing traditional glucose-centric assays. This narrative highlights actionable protocols, troubleshooting, and recent advances, positioning Canagliflozin from APExBIO as a gold-standard tool for translational metabolic research.

• Gamma-linolenic acid (GLA, SKU C5518): Best Practices for...

  2026-04-10

  This scenario-driven guide details how Gamma-linolenic acid (GLA, SKU C5518) addresses persistent laboratory challenges in cell viability, proliferation, and cytotoxicity workflows. With robust literature support and practical optimization tips, researchers gain actionable, data-backed strategies for integrating GLA into inflammation and apoptosis assays, while ensuring reproducibility and safety.

453 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page